BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:01 PM
 | 
Aug 20, 2009
 |  BC Extra  |  Company News

FDA approves GSK's Hiberix

FDA granted accelerated approval to a BLA for Hiberix Haemophilus influenzae type B (Hib) vaccine from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK)...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >